Source:http://linkedlifedata.com/resource/pubmed/id/18793139
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 5
|
pubmed:dateCreated |
2008-9-16
|
pubmed:abstractText |
The ubiquitin ligase E6-AP (E6-associated protein) represents a prime example for the notion that deregulated modification of proteins with ubiquitin contributes to the development of human disease: loss of E6-AP function by mutation is responsible for the development of AS (Angelman syndrome), a neurological disorder, and unscheduled activation of E6-AP by complex formation with the E6 oncoprotein of HPVs (human papillomaviruses) contributes to cervical carcinogenesis. However, while there is a considerable amount of data concerning the oncogenic properties of the E6-E6-AP complex, only little is known about the function(s) of E6-AP in neurons. This is mainly due to the fact that although some E6-AP substrates have been identified, it is at present unclear whether deregulated modification/degradation of these proteins is involved in the pathogenesis of AS. Similarly, the cellular pathways involving E6-AP remain enigmatic. To obtain insights into the physiological functions of E6-AP, we are currently employing several strategies, including quantitative affinity proteomics and RNA interference approaches. The results obtained will eventually allow the introduction of E6-AP into functional protein networks and so reveal potential targets for molecular approaches in the treatment of E6-AP-associated diseases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/E6 protein, Human papillomavirus...,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/UBE3A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Protein Ligases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0300-5127
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
797-801
|
pubmed:meshHeading |
pubmed-meshheading:18793139-Angelman Syndrome,
pubmed-meshheading:18793139-Animals,
pubmed-meshheading:18793139-DNA-Binding Proteins,
pubmed-meshheading:18793139-Enzyme Activation,
pubmed-meshheading:18793139-Female,
pubmed-meshheading:18793139-Humans,
pubmed-meshheading:18793139-Mice,
pubmed-meshheading:18793139-Mice, Knockout,
pubmed-meshheading:18793139-Oncogene Proteins, Viral,
pubmed-meshheading:18793139-Ubiquitin-Protein Ligases,
pubmed-meshheading:18793139-Uterine Cervical Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
Ubiquitin ligase E6-AP and its role in human disease.
|
pubmed:affiliation |
Laboratory of Cellular Biochemistry, Department of Biology, University of Konstanz, 78457 Konstanz, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|